Find Your Voice: How This Acclaimed Australian Soprano Believes That Together We Can Change The World One Voice At A Time
Finding Genius Podcast, 24 December, 2022
Our Executive Director Tania de Jong AM was interviewed in this podcast about her work with mental health charities Creativity Australia and Mind Medicine Australia.
From Investment Banking To Psychedelics: Changing The Treatment Paradigm For Mental Illness With Peter Hunt
Wake the f*** up podcast, 21 December, 2022
This podcast is an exploration into Peter Hunt’s journey into spirituality and finding greater connection, meaning and peace which led to the establishment of Mind Medicine Australia with his wife Tania de Jong. It also explains why it is so urgent for psychedelic-assisted therapies to become part of our mental health system and the importance of Governments becoming proactive in this field, rather than reactive. There is so much suffering which could be alleviated through these transformational therapies.
Emyria to expand Real World Data assets for MDMA-assisted therapy trials by incorporating wearables monitoring
Emyria (ASX: EMD ) Press Release, 20 December, 2022
Emyria’s phase 2b MDMA-assisted therapy trial for severe Post Traumatic Stress Disorder (PTSD), EMDMA-001, developed with registered charity Mind Medicine Australia (MMA), will be the first program to incorporate Cydelic technology and is expected to be one of the first programs in the world to incorporate remote patient monitoring within MDMA-assisted therapy.
The Wellness Couch Podcast, Episode #92 with Tania de Jong AM
The Wellness Couch Podcast, 16 December, 2022
In this podcast, Mind Medicine Australia Executive Director, Tania de Jong AM, shares more about psychedelic-assisted psychotherapies and their potential for healing mental illness.
TGA blocks bid to have MDMA, magic mushrooms used to treat mental health conditions
ABC News, 16 December, 2022
Australia’s medicines regulator has rejected a call to legalise psychedelic drugs for use in mental health settings.
TGA says NO again to psychedelic-assisted therapies
Mind Medicine Australia, 15 December, 2022
Mind Medicine Australia’s Response to the Announcement of the TGA NOT to Reschedule the Medical Use of MDMA for Treatment Resistant PTSD and the Medical Use of Psilocybin for Treatment Resistant Depression as Part of Therapy.
MDMA and psilocybin could be removed from the TGA’s list of prohibited medicines
ABC RN Breakfast, 03 December, 2022
In this interview MMA Ambassador, Prof David Nutt (UK), speaks about Australia’s drug regulator, the Therapeutic Goods Administration, who is soon set to announce if psilocybin and MDMA should be removed from the prohibited medicines list: “I have to say, one of the things I have been doing a lot here is teaching on Mind Medicine Australia training course which I think is the best course in the world on educating people about how to use psychedelics and how to develop.” (6:19 onwards)
Return trip: Psychedelics have made a comeback in the treatment of mental illness
Wellspring Mag, 01 December, 2022
In this interview, Tania de Jong AM, Executive Director at Mind Medicine Australia, discusses the re-emergence of psychedelic-assisted therapy.
A former defence force chief has joined a push to treat post traumatic stress disorder with MDMA
9News, 18 November, 2022
Admiral Chris Barrie AC, a former Defence Force Chief from our board and Veteran Michael Raymond were recently interviewed on 9News. We are advocating for psychedelic medicines which can offer hope to those suffering from severe PTSD and depression.
TGA considering change to classification of psychedelics
ABC News, 17 November, 2022
Psychiatrist Dr Stuart Saker says there’s compelling evidence that some psychedelic drugs make effective treatments for people with post-traumatic stress disorder or depression.
Clinical use of psilocybin
9News Gold Coast, 22 October, 2022
The clinical use of psilocybin and MDMA to treat mental illness could soon be available to every Australian. A former Rugby player and Gold Cost local now throwing his support behind the approach.
TGA review psychedelics for mental health treatment
ABC, RN Breakfast, 07 October, 2022
Andrew Robb AO, MMA Board Member and previously the Australian Government Minister for Trade, speaks on Radio National about the urgent need to reschedule the medical use of MDMA and Psilocybin as part of therapy for the treatment of depression and PTSD.
Tasmanian mental health patients “holding out hope” for MDMA and magic mushrooms treatments
The Advocate, 01 October, 2022
The legal use of MDMA and psilocybin as treatments for mental health conditions such as anxiety and post-traumatic stress disorder could potentially be one step closer, with the national drugs regulator finding they have therapeutic benefits.
Magic Mushrooms and MDMA could be approved for mental health conditions by TGA
Herald Sun, 01 October, 2022
MDMA and Psilocybin have moved a step closer to being approved for use in mental health in Australia.
‘Psychedelics renaissance’: new wave of research puts hallucinogenics forward to treat mental health
The Guardian, 26 September, 2022
In what’s been described as a ‘paradigm shifter’ for psychiatry, Australian clinical trials are exploring the therapeutic benefits of illegal substances.
Legalising Illicit Therapies: Why Psychedelics Could Be The Most Important Mental Health Breakthrough Of The 21st Century
Refinery29, 17 September, 2022
Why Psychedelics Could Be The Most Important Mental Health Breakthrough Of The 21st Century.
How Mind Medicine Australia Is Tackling Deadly Mental Health Crisis with Psychedelics
Psychedelic Spotlight, 16 September, 2022
Charity co-founder Tania de Jong says Covid-19 pandemic has led to “a huge spike in mental health issues including, very sadly, suicides,” and she believes psychedelics are a solution.
Magic Mushrooms // The Medicine That Can Change Your Life
Carnage House Productions, 16 September, 2022
This interview with Tania de Jong AM, focuses on the benefits of psilocybin and MDMA assisted therapies for sufferers of depression, anxiety, PTSD and alcohol/nicotine addiction.